Cargando…

PSUN181 Diabetes-related outcomes following use of basal-bolus insulin vs. premixed insulin in a VA population with Type 2 diabetes: A retrospective chart review.

BACKGROUND: Treatment of diabetes mellitus (DM) with basal bolus insulin analogs (BB) requires up to five injections a day. The complexity of BB therapy may adversely influence patient compliance. A simpler and cheaper regimen with premixed insulin (PM) typically involves two injections a day but is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Izuora, Kenneth, Batra, Kavita, Bai, Ravisha, Yap, Charmaine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625055/ http://dx.doi.org/10.1210/jendso/bvac150.775

Ejemplares similares

PSUN227 A retrospective comparison of Basal Bolus using Glargine U-300 and Glulisine with Premix Insulin
por: Abraham, Santhosh, et al.
Publicado: (2022)

Combination Therapy With Premixed & Basal Insulin Analogues in Asian Indians With Type 2 Diabetes
por: Srivastava, Brijendra Kumar, et al.
Publicado: (2021)

Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
por: Bellido, Virginia, et al.
Publicado: (2015)

Basal-bolus or premixed? Shedding light on optimal insulin regime for type 1 diabetes
por: Louise Walton, Emma
Publicado: (2018)

PSUN281 Safety and Efficacy of Virtual Insulin Pump Initiation in Adults with Diabetes
por: Everett, Estelle, et al.
Publicado: (2022)

Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs: When and for whom?
por: Mosenzon, Ofri, et al.
Publicado: (2013)

Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes
por: Mehta, Roopa, et al.
Publicado: (2022)

PSUN264 Insulin Edema: A rare side effect of Intensive Insulin Therapy
por: Abramowitz, Jessica, et al.
Publicado: (2022)

Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals
por: Lamos, Elizabeth Mary, et al.
Publicado: (2015)

PSUN173 Factors determining insulin dose while transitioning from intravenous insulin infusion to subcutaneous insulin in patients with type 2 diabetes following cardiac bypass surgery.
por: Bansal, Beena, et al.
Publicado: (2022)

RF28 | PSUN216 Insulin Use Among Asian and Pacific Islander Adults with Diabetes Receiving Pharmacotherapy
por: Yin, Chelsea, et al.
Publicado: (2022)

Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin
por: van Brunt, Kate, et al.
Publicado: (2016)

A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes
por: Miyoshi, Hideaki, et al.
Publicado: (2021)

PSUN278 Factitious hypoglycemia, diagnostic delay due to insulin assay failure to detect insulin analogues.
por: Harned, Leighton Kahle, et al.
Publicado: (2022)

The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
por: Castellano, Elena, et al.
Publicado: (2018)

Predicting the Need for Basal-Bolus Insulin in Hospitalized Patients With Hyperglycemia: Is Sliding Scale Sometimes the Answer?
por: Jankovic, Ivana, et al.
Publicado: (2021)

PSUN239 Severe Insulin Resistance and Hyperglycemia with Mild COVID-19 Infection
por: Azmath, Misbah, et al.
Publicado: (2022)

PSUN304 CRN04777 an Oral, Nonpeptide SST5-selective Somatostatin Agonist Dose Dependently Suppresses Basal and Stimulated Insulin Secretion
por: Ferrara-Cook, Christine, et al.
Publicado: (2022)

Correction to: The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
por: Castellano, Elena, et al.
Publicado: (2018)

PSUN274 Chlorthalidone-Induced Diabetic Ketoacidosis.
por: Zafar, Rafia, et al.
Publicado: (2022)

Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus
por: Ito, Hiroyuki, et al.
Publicado: (2014)

PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity
por: Eyupoglu, Nesrin Damla, et al.
Publicado: (2022)

RF04 | PSUN233 Design of an Ultra-Stable Insulin/Glucagon Fusion Protein
por: Grabowski, Rachel, et al.
Publicado: (2022)

PSUN314 Severe Insulin Resistance Impacts the Growth Hormone-Insulin-Like Growth Factor-I Axis and Linear Growth
por: Okawa, Marinna
Publicado: (2022)

Abstract #1183942: Thyroid myopathy after receiving COVID-19 Vaccine
por: Bai, Ravisha, et al.
Publicado: (2022)

Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens
por: Shi, Li Xin, et al.
Publicado: (2017)

PSUN192 Therapeutic Benefit of GLP-1 Agonists in Patients with Type 1 Diabetes on Insulin Therapy: an Updated Systematic Review and Meta-analysis
por: Park, Jeayoung, et al.
Publicado: (2022)

Association of diabetic ketoacidosis, severe hypoglycemia and glycemic control among children and young adults with type 1 diabetes mellitus treated with premixed versus basal-bolus insulin therapy
por: Chou, Wei-Yu, et al.
Publicado: (2018)

PSUN248 Mitochondrial diabetes - a rare but important cause of diabetes
por: Botros, Mina, et al.
Publicado: (2022)

PSUN299 GLP-1 Contribution to Insulin Secretory Response to Protein Ingestion and Insulin Kinetics Following Gastric Bypass and Sleeve Gastrectomy
por: Rayas, Maria, et al.
Publicado: (2022)

PSUN169 Vitamin C Renal Leak in Diabetes
por: Ebenuwa, Ifechukwude, et al.
Publicado: (2022)

Trajectory of Glycated Hemoglobin Over Time Among Obese Type 2 Diabetes Patients on U-100 Basal-Bolus Insulin Regimen Using Real-World Data
por: Chen, Jieling, et al.
Publicado: (2021)

FRI642 The Effect Of Early Basal Insulin Administration On Diabetic Ketoacidosis (DKA) Management
por: Al-Marsumi, Hadeel, et al.
Publicado: (2023)

PSUN260 Diabetic Myconecrosis: a Rare Complication of Uncontrolled Diabetes Mellitus
por: Joseph, Marina, et al.
Publicado: (2022)

PSUN220 Audit on Variable Rate Intravenous Insulin Infusion (VRIII) in inpatients in Scarborough General Hospital
por: Abraham, Santhosh, et al.
Publicado: (2022)

MON-653 The Effects of DPP IV Inhibitor on Glycemic Variability in Type 2 Diabetic Patients Treated with Twice Daily Premixed Human Insulin
por: Tan, Florence Hui Sieng, et al.
Publicado: (2020)

PSUN176 Fructosamine as a screening test for gestational diabetes
por: Kabadi, Udaya, et al.
Publicado: (2022)

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
por: Bergenstal, Richard M., et al.
Publicado: (2019)

PSUN196 Outcomes following SGLT-2 inhibitor use in 99 patients with type 1 diabetes: A single-centre, retrospective, chart-review study
por: William, Jovitta, et al.
Publicado: (2022)

PSUN261 Diabetic Ketoacidosis Complicating Gestational Diabetes Mellitus: A Case Report
por: Villavicencio, Camila, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_90vppeu1s0h7ff4o2c4qvucjn4